about
Eosinophils mediate protective immunity against secondary nematode infection.Coinjection with TLR2 agonist Pam3CSK4 reduces the pathology of leishmanization in mice.Eosinophils and IL-4 Support Nematode Growth Coincident with an Innate Response to Tissue Injury.Immune activation of the host cell induces drug tolerance in Mycobacterium tuberculosis both in vitro and in vivo.The Minimal Unit of Infection: Mycobacterium tuberculosis in the Macrophage.The antituberculosis drug pyrazinamide affects the course of cutaneous leishmaniasis in vivo and increases activation of macrophages and dendritic cells.Eosinophil-derived IL-10 supports chronic nematode infection.Characterization, expression and evolution analysis of Toll-like receptor 1 gene in pufferfish (Tetraodon nigroviridis).A live Leishmania major vaccine containing CpG motifs induces the de novo generation of Th17 cells in C57BL/6 mice.Protective immunity against tuberculosis: what does it look like and how do we find it?Matrix metalloproteinase inhibitors enhance the efficacy of frontline drugs against Mycobacterium tuberculosis.Growth of Mycobacterium tuberculosis in vivo segregates with host macrophage metabolism and ontogeny.The Deconstructed Granuloma: A Complex High-Throughput Drug Screening Platform for the Discovery of Host-Directed Therapeutics Against TuberculosisThe genetic requirements of fatty acid import by within macrophagesExploitation of Synthetic mRNA To Drive Immune Effector Cell Recruitment and Functional Reprogramming In VivoImmunometabolism at the interface between macrophages and pathogensInflammaging is associated with shifted macrophage ontogeny and polarization in the aging mouse ovaryDual RNA-Seq of Mtb-Infected Macrophages In Vivo Reveals Ontologically Distinct Host-Pathogen Interactions
P50
Q34749460-0DC21A57-CAE2-4EE7-AE4C-A9794853AD4DQ35571431-C9D5B8E8-8890-445D-BB3C-C91179E3DA5CQ35882698-91A7CF53-B866-44F7-97BA-FFEAC12906CCQ36863134-AF7B7A44-787A-403A-9FD6-E0B252D57B9EQ37594360-AAA98F19-5484-406A-8CD9-ED9D98E8F6F3Q39796781-A45C657C-BB46-4087-B821-8995A42409ECQ41743992-E1981228-C1F6-4EEC-9DAF-F53B65497FCFQ42647000-F657E2E6-295B-424A-8D3B-0ED1524C99B9Q42670769-84F94344-2682-4D25-B327-E33A974D954FQ47159329-DA89F746-8C50-4971-B6C1-2B0A841A5C5BQ52561219-7BCA4EEE-60F4-4B1A-AE60-F8704E04EB5FQ54263042-2809AF88-DF75-4918-AA7A-E3051937962FQ58781465-E8CAF4F6-17D4-44D1-A7CB-5F99002FB499Q61797368-177699E5-18EB-4C68-9D62-9AF2B0649805Q90435998-DBE7541D-054B-4EF5-B000-FBA5BDD2F287Q91212060-244B3C82-22AB-4BDF-9637-A659B1D99EDFQ92658274-70BD1B80-8449-40F7-9607-1E352257D6ACQ92659581-93B11C59-5CEB-482A-96C4-45F559E32952
P50
description
researcher ORCID ID = 0000-0002-7820-2177
@en
name
Lu Huang
@ast
Lu Huang
@en
Lu Huang
@nl
type
label
Lu Huang
@ast
Lu Huang
@en
Lu Huang
@nl
prefLabel
Lu Huang
@ast
Lu Huang
@en
Lu Huang
@nl
P31
P496
0000-0002-7820-2177